Retrovirus vector containing wild type p53 gene and its effect on human glioma cells

Neoplasma

Volumn 47, Issue 4, 2000, Pages 204-211

  Hlavaty, J ^a   Tyukosova, S ^a   Bies, J ^a   Hlubinova, K ^a   Altaner, C ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Gene therapy; p53 gene; Retrovirus vector

Indexed keywords

PROTEIN P53; VIRUS VECTOR;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; DNA REPAIR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSCRIPTION; GLIOMA CELL; HUMAN; HUMAN CELL; SUICIDE GENE; TUMOR SUPPRESSOR GENE;

EID: 0033851248     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Adenovirus-mediated p53 gene delivery potentates the radiation-induced growth inhibition of experimental brain tumors
2. Suppression of human colorectal carcinoma cell growth by wild-type p53
3. Acceleration of apoptosis in transforming growth factor β1-treated M1 cells ectopically expressed B-myb
4. In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug
5. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells
6. p53 levels, functional domains, and DNA damage determine the extent of apoptotic response of tumor cells
7. The tumor suppressor p53 regulates its own transcription
8. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function
9. WAF1, a potential mediator of p53 tumor suppression
10. Overexpresssion of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo
11. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene
12. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity
13. Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53
14. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis
15. Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis
16. Adenovirus-mediatedd p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer
17. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
18. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
19. Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene
20. Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene
21. Gene therapy for glioblastoma in adult patients: Safety and efficacy evaluation of an in situ injection of recombinant retrovirus-producing cells carrying the thymidine kinase gene of the herpes simplex type 1 virus, to be followed with the administration of ganciclovir
22. Gene therapy for metastatic malignant melanoma: Evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type II thymidine kinase gene, to be followed by ganciclovir administration
23. A phase I/II study of herpes simplex virus type I thymidine kinase 'suicide' gene therapy for recurrent glioblastoma
24. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo
25. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene
26. p53, the cellular gatekeeper for growth and division
27. Adenovirus-mediated wilde-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status
28. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus
29. Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges
30. A safe packaging line for gene transfer: Separating viral genes on two different plasmids
31. Construction and use of a safe and efficient amphotropic packaging cell line
32. Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer
33. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
34. p53 tumor suppressor gene therapy for cancer
35. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer
36. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent
37. Sensitive colorimetric bioassay for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption Use in studies of IGF analogs
38. Characterization of two new permanent glioma cell lines 8-MG-BA and 42-MG-BA
39. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
40. Gene transfer of wild-type p53 results in restoration of tumor-suppressor function in a meduloblastoma cell line
41. Retrovirus mediated wild-type p53 gene transfer to tumors of patients with lung cancer
42. A phase I of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer
43. 2 to M transition: Implications for gene therapy
44. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas
45. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation
46. Chemosensitivity of human malignant glioma Modulation by p53 gene transfer
47. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin6